Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Metamucil capsules

This article was originally published in The Tan Sheet

Executive Summary

P&G ads for latest extension of laxative powders, wafers brand will focus on convenience, portability, firm says. TV, radio, print ad campaign designed by D'Arcy Masius Benton & Bowles (New York) will launch once capsules reach 50% distribution. Product began reaching shelves Sept. 30, with full distribution expected by mid-December. Capsules are sold in 100-, 160-count bottles with SRP of $7.99-$9.99 and $9.99-$12.99, respectively. Each dose of two to six capsules contains roughly 3.4 g of psyllium husk (2.4 g soluble fiber); consumers are advised to take up to three doses per day with 8 oz. of water. Metamucil's dual benefit as fiber supplement that may carry FDA-approved heart disease risk-reduction health claim could help propel line extension to top of the branded laxatives tablet category, which is now led by Novartis' Dulcolax, Ex-Lax, according to IRI data...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS094619

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel